EurekAlert! Cancer Research

News Releases

Updates every hour. Last Updated: 24-Jun-2026 00:16 ET (24-Jun-2026 04:16 GMT/UTC)

11-Feb-2026

Multiple myeloma: Established cancer drug reactivates immunotherapy

Technical University of Munich (TUM)
Peer-Reviewed Publication

Genetically modified immune cells can offer precious additional time to patients with advanced multiple myeloma. However, these therapies lose their impact as the molecules on cancer cells that immune cells recognize gradually vanish. Researchers at the Technical University of Munich (TUM) have now identified one of the molecular mechanisms behind this process. In an initial study they succeeded in blocking it using an existing cancer drug.

Journal: Blood

11-Feb-2026

Aggressive brain tumors build protective “sugar shield” to survive extreme stress

Lund University
Peer-Reviewed Publication

For the first time, researchers have identified a previously unrecognized metabolic defence mechanism in aggressive brain tumours: a sugar-rich shield that surrounds tumour cells and protects them against a particularly destructive form of cell death.

Journal: Nature Cell Biology
Funder: The Swedish Research Council, The Swedish Cancer Society, The Swedish Childhood Cancer Fund, Mrs. Berta Kamprad’s Cancer Foundation, The Sjöberg Foundation, ALF, Viveca Jeppsson

11-Feb-2026

Molecule found to drive skin cancer growth and evade immune detection

NYU Langone Health / NYU Grossman School of Medicine
Peer-Reviewed Publication

A molecule that helps regulate gene activity has also been shown to drive skin cancer growth and tumors’ ability to evade attack by the body’s immune system, a new study shows.

Journal: Cancer Discovery

11-Feb-2026

Osimertinib ± savolitinib in MET-EGFR NSCLC trial

Maximum Academic Press
Peer-Reviewed Publication

A groundbreaking phase 2 clinical trial has unveiled promising advancements in the treatment landscape for non-small cell lung cancer (NSCLC), specifically targeting patients harboring epidermal growth factor receptor (EGFR) mutations alongside MET gene aberrations.

Journal: Nature Communications

11-Feb-2026

DNA barcoding reveals the complexity of breast cancer liquid biopsies

Olivia Newton-John Cancer Research Institute
Peer-Reviewed Publication

DNA barcoding can be used to track cancer cells in solid and liquid biopsies, empowering future research into more reliable breast cancer diagnosis and treatment strategies.

Journal: Molecular Systems Biology
Funder: National Breast Cancer Foundation, National Health and Medical Research Council, Love Your Sister

11-Feb-2026

Does a past abortion or miscarriage affect a woman’s risk of developing breast cancer?

Wiley
Peer-Reviewed Publication

A prior abortion or miscarriage was not linked with an increased risk of developing pre- or postmenopausal breast cancer in a study published in Acta Obstetricia et Gynecologica Scandinavica.

Journal: Acta Obstetricia Et Gynecologica Scandinavica

11-Feb-2026

Could a treatment redirect the body’s anti-viral immune response to target cancer cells?

Wiley
Peer-Reviewed Publication

Because many different types of cancer cells overexpress programmed death-ligand 1 (PD-L1), this cell surface protein is a major target of cancer immunotherapy. Unfortunately, drugs that target it do not trigger especially strong anti-cancer immune responses. New research published in Advanced Science reveals a promising strategy that harnesses pre-existing antiviral immunity to boost anti-tumor responses.

Journal: Advanced Science

10-Feb-2026

Biomarkers predict patients with glioblastoma who will survive longer after treatment with cancer-targeting virus

University of Texas M. D. Anderson Cancer Center
Peer-Reviewed Publication

Glioblastoma is a deadly brain cancer that suppresses the immune system and doesn’t respond well to available therapies

Researchers engineered a cancer-targeting virus that can be injected directly in glioblastoma tumors

Adding an immune booster to the virus increased the length of survival in a subset of patients and helped identify blood biomarkers in patients most likely to benefit

Journal: Clinical Cancer Research

10-Feb-2026

Growth of spreading pancreatic cancer fueled by 'under-appreciated' epigenetic changes

Johns Hopkins Medicine
Peer-Reviewed Publication

In a lab-grown cell study focused on potential new treatment targets for halting the spread of most pancreatic cancers, Johns Hopkins Medicine scientists report they have found that a gene called KLF5 (Krueppel-like factor 5) fuels the growth of such spreading tumors not by acquiring abnormal changes in the cancer cells’ DNA code itself but by altering chemical changes and organization of DNA, or epigenetics, that turns genes on and off

Journal: Molecular Cancer
Funder: National Institutes of Health, Celgene License Pathway Agreement, A gift from the friends and family of Jasmine Lampadarios.

10-Feb-2026

University of South Alabama Research named Top 10 Scientific Breakthroughs of 2025

University of South Alabama
Grant and Award Announcement

Dr. Simon Grelet, with the University of South Alabama's Mitchell Cancer Institute, has identified a novel mechanism by which neurons transfer mitochondria — the cell’s energy-producing structures — to cancer cells. This interaction fuels cancer metastasis and opens new possibilities for therapeutic intervention.